Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 1998

View Archived Issues

Novel flavonoid derivative SU-840 with potent gastroprotective and ulcer-healing effects

Treatment with recombinant IL-1 receptor safe in HIV-infected patients

OPC-14117: tolerability and safety as antioxidant therapy for Huntington's disease

HIV protease inhibitors developed by research group at Sankyo

Blockade of angiotensin II receptor reduces radiation-induced renal and lung injury

Zeneca forms new subsidiary in Taiwan

Unigene and Warner-Lambert accelerate development of oral calcitonin product

Genta and NCI to collaborate on G-3139 development

Granocyte granted expanded marketing authorization

U.S. patent issues for second product in PathoGenesis' pipeline

Novel antitumor agent discovered by Banyu

Taisho claims potent and selective D4 receptor antagonists

Carcinostatic agents developed at Toagosei

ACAT inhibitors from SS Pharm. for atherosclerosis

Investigation at Kowa results in development of potent CysLT1 receptor antagonists

Series of MMP and TACE inhibitors patented by American Cyanamid

GRP antagonist inhibits pancreatic carcinoma growth in vitro and in vivo

New antimigraine option now available in Canada

Ganaxolone study results presented at AASH meeting

Sankyo overseas clinical pipeline

CNS-selective effects of synthetic, nonfeminizing estrogens

Immunex and American Home Products restructure collaboration

Pasteur Merieux Connaught's AIDS vaccine pipeline in review

Nonsteroidal antiestrogen EM-800 shows potential in breast cancer, osteoporosis

Phase I/II trial of gene therapy to treat peripheral vascular disease

BTG offers paclitaxel analogues for licensing

Phase Ia clinical trial with NIF for ischemic stroke completed by Pfizer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...